Sunovion Pharma Completes Acquisition of Cynapsus Therapeutics (CYNA)
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 4/23/2024
- Wall Street closes higher as investors digest earnings, megacap outlook
- Tesla touts acceleration of new models, but Q1 results fall short of estimates
- JPMorgan is worried about further S&P 500 sell-off potential
- Oil rises as dollar slips, focus shifts to economic data
- China acquired top-end Nvidia AI chips despite recent US ban- Reuters
- Fisker (FSR) Appoints Michael Healy as Chief Restructuring Officer
- Kroger (KR), Albertsons and C&S Wholesale Grocers Announce an Updated and Expanded Divestiture Plan
- Costar Group (CSGP) to Acquire Matterport (MTTR) for $5.50/sh Cash and Stock
- Jaguar Health (JAGX) Files $75M Mixed Shelf
- Apple (AAPL) PT Lowered to $210 at Morgan Stanley, 'We'd buy post-earnings weakness'
- After-hours movers: Tesla, Texas Instruments, Seagate, Visa and more
- Midday movers: PepsiCo, JetBlue fall; GM, Danaher and UPS rise
- After-hours movers: Cadence Design Systems, Cleveland-Cliffs, Riot Platforms, and more
- Midday movers: Tesla, Li Auto and CNH Industrial fall; Salesforce rises
- Midday movers: Netflix, Super Micro fall; Paramount Global gains
Form 25-NSE Cynapsus Therapeutics Filed by: NASDAQ Stock Market LLC
October 21, 2016 9:22 AM EDTX0203 0001354457 NASDAQ Stock Market LLC 0001532079 Cynapsus Therapeutics Inc. 001-37426 28 Richmond Street West Toronto A6 ONTARIO, CANADA M6J 1C9 CA 416-703-2449 Common Shares 17 CFR 240.12d2-2(a)(3) Tara Petta Director 2016-10-21 cyna-form25... More
